Developing the peripheral market through peripheral balloon catheters
First written in FY2018-Q1. 3 of 4 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2018.
4 other companies' latest entry also says "Advanced".
- FY2018AdvancedAnnual report
「Balloon catheter sales increased from the previous fiscal year, helped by MASTULY, a peripheral product launched in June last year.」
Sales increased with contributions from the peripheral balloon catheter Mastuly, with the expansion into peripheral applications reflected in sales performance. - FY2018-Q3AdvancedAnnual report
「Balloon catheter sales remained firm for coronary applications, while sales volumes increased for Mastuly, a peripheral balloon catheter for lower-limb applications that we began selling in June last year.」
Mastuly sales volumes increased, advancing the company's expansion in peripheral applications. - FY2018-Q2AdvancedAnnual report
「Balloon catheter sales remained firm for coronary applications, while sales volumes increased for Mastuly, a peripheral balloon catheter for lower-limb applications that we began selling in June this year.」
Sales volumes of Mastuly, launched in June 2017, increased, advancing the company's expansion in peripheral applications for lower-limb treatment. - FY2018-Q1First statedAnnual report
「In June this year, we began selling Mastuly, a peripheral balloon catheter that we are handling for the first time. The product has already been highly regarded in clinical settings for its ability to pass through lesions and its excellent maneuverability, and we aim to expand into peripheral applications by increasing sales going forward.」
Mastuly sales began in June 2017, with the company targeting expansion into peripheral applications through increased sales.